Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041468663> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2041468663 endingPage "PR02" @default.
- W2041468663 startingPage "PR02" @default.
- W2041468663 abstract "Abstract The tumor suppressor Retinoblastoma protein (Rb) is often inactivated in cancer. In many tumors, the Rb protein itself is retained but functionally inactivated by increased CDK4/6 kinase activity. A number of key oncogenic aberrations can result in this increased activity, including inactivation of CDKN2A (p16), translocation or amplification of D-cyclins, amplification of CDK4/6 and mutations/deletions upstream of cyclin D, such as activating mutations of BRAF/PIK3CA and PTEN deletion. Abolishing CDK4/6 kinase activity and subsequent reactivation of Rb in these tumors has been demonstrated to inhibit tumor initiation and growth. Here we will describe LEE011- an orally bioavailable, selective small molecule inhibitor of CDK4/6 kinases. LEE011 inhibits CDK4/6 kinase activity with nM IC50 and is highly selective for these targets. In a number of preclinical tumor models, LEE011 demonstrates a dose dependent anti-tumor activity that tracks well with CDK4/6 inhibition. The primary mechanism for growth inhibitory effect appears to be G1 arrest in vitro, although, in some sensitive in vivo models, regressions are observed. Importantly, given the role of CDK4/6 downstream of other oncogenic driver mutations, LEE011 shows single agent activity in melanomas with activating mutations of BRAF or NRAS, and in breast cancers with intact estrogen receptor and/or activating aberrations of PIK3CA/Her-2. Combining LEE011 with LGX818, a V600E BRAF specific inhibitor, leads to robust anti-tumor activity in melanoma models that are both sensitive and, importantly, those that are resistant to LGX818. Furthermore, combining LEE011 with BYL719, a PIK3CA specific inhibitor, also leads to significant anti-tumor activity in breast cancer models both sensitive and resistant to BYL719. Several clinical studies evaluating LEE011 as single agent and in combinations are underway. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):PR02. Citation Format: Sunkyu Kim, Alice Loo, Rajiv Chopra, Giordano Caponigro, Alan Huang, Sadhna Vora, Sudha Parasuraman, Steve Howard, Nicholas Keen, William Sellers, Christopher Brain. LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6– Reactivating Rb in cancer. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr PR02." @default.
- W2041468663 created "2016-06-24" @default.
- W2041468663 creator A5000850685 @default.
- W2041468663 creator A5025118565 @default.
- W2041468663 creator A5029524329 @default.
- W2041468663 creator A5043647084 @default.
- W2041468663 creator A5044141815 @default.
- W2041468663 creator A5057024955 @default.
- W2041468663 creator A5057346782 @default.
- W2041468663 creator A5058817270 @default.
- W2041468663 creator A5070795361 @default.
- W2041468663 creator A5086182006 @default.
- W2041468663 creator A5087956058 @default.
- W2041468663 date "2013-11-01" @default.
- W2041468663 modified "2023-10-16" @default.
- W2041468663 title "Abstract PR02: LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6– Reactivating Rb in cancer." @default.
- W2041468663 doi "https://doi.org/10.1158/1535-7163.targ-13-pr02" @default.
- W2041468663 hasPublicationYear "2013" @default.
- W2041468663 type Work @default.
- W2041468663 sameAs 2041468663 @default.
- W2041468663 citedByCount "68" @default.
- W2041468663 countsByYear W20414686632014 @default.
- W2041468663 countsByYear W20414686632015 @default.
- W2041468663 countsByYear W20414686632016 @default.
- W2041468663 countsByYear W20414686632017 @default.
- W2041468663 countsByYear W20414686632018 @default.
- W2041468663 countsByYear W20414686632019 @default.
- W2041468663 countsByYear W20414686632020 @default.
- W2041468663 countsByYear W20414686632021 @default.
- W2041468663 countsByYear W20414686632022 @default.
- W2041468663 countsByYear W20414686632023 @default.
- W2041468663 crossrefType "journal-article" @default.
- W2041468663 hasAuthorship W2041468663A5000850685 @default.
- W2041468663 hasAuthorship W2041468663A5025118565 @default.
- W2041468663 hasAuthorship W2041468663A5029524329 @default.
- W2041468663 hasAuthorship W2041468663A5043647084 @default.
- W2041468663 hasAuthorship W2041468663A5044141815 @default.
- W2041468663 hasAuthorship W2041468663A5057024955 @default.
- W2041468663 hasAuthorship W2041468663A5057346782 @default.
- W2041468663 hasAuthorship W2041468663A5058817270 @default.
- W2041468663 hasAuthorship W2041468663A5070795361 @default.
- W2041468663 hasAuthorship W2041468663A5086182006 @default.
- W2041468663 hasAuthorship W2041468663A5087956058 @default.
- W2041468663 hasConcept C121608353 @default.
- W2041468663 hasConcept C153911025 @default.
- W2041468663 hasConcept C184235292 @default.
- W2041468663 hasConcept C185592680 @default.
- W2041468663 hasConcept C199649820 @default.
- W2041468663 hasConcept C2775930923 @default.
- W2041468663 hasConcept C2776062698 @default.
- W2041468663 hasConcept C2779744173 @default.
- W2041468663 hasConcept C2780265364 @default.
- W2041468663 hasConcept C29537977 @default.
- W2041468663 hasConcept C502942594 @default.
- W2041468663 hasConcept C51853150 @default.
- W2041468663 hasConcept C530470458 @default.
- W2041468663 hasConcept C54355233 @default.
- W2041468663 hasConcept C82495950 @default.
- W2041468663 hasConcept C86803240 @default.
- W2041468663 hasConcept C95444343 @default.
- W2041468663 hasConcept C97029542 @default.
- W2041468663 hasConceptScore W2041468663C121608353 @default.
- W2041468663 hasConceptScore W2041468663C153911025 @default.
- W2041468663 hasConceptScore W2041468663C184235292 @default.
- W2041468663 hasConceptScore W2041468663C185592680 @default.
- W2041468663 hasConceptScore W2041468663C199649820 @default.
- W2041468663 hasConceptScore W2041468663C2775930923 @default.
- W2041468663 hasConceptScore W2041468663C2776062698 @default.
- W2041468663 hasConceptScore W2041468663C2779744173 @default.
- W2041468663 hasConceptScore W2041468663C2780265364 @default.
- W2041468663 hasConceptScore W2041468663C29537977 @default.
- W2041468663 hasConceptScore W2041468663C502942594 @default.
- W2041468663 hasConceptScore W2041468663C51853150 @default.
- W2041468663 hasConceptScore W2041468663C530470458 @default.
- W2041468663 hasConceptScore W2041468663C54355233 @default.
- W2041468663 hasConceptScore W2041468663C82495950 @default.
- W2041468663 hasConceptScore W2041468663C86803240 @default.
- W2041468663 hasConceptScore W2041468663C95444343 @default.
- W2041468663 hasConceptScore W2041468663C97029542 @default.
- W2041468663 hasIssue "11_Supplement" @default.
- W2041468663 hasLocation W20414686631 @default.
- W2041468663 hasOpenAccess W2041468663 @default.
- W2041468663 hasPrimaryLocation W20414686631 @default.
- W2041468663 hasRelatedWork W2017791020 @default.
- W2041468663 hasRelatedWork W2041468663 @default.
- W2041468663 hasRelatedWork W2099380351 @default.
- W2041468663 hasRelatedWork W2145657367 @default.
- W2041468663 hasRelatedWork W2885602815 @default.
- W2041468663 hasRelatedWork W3125289280 @default.
- W2041468663 hasRelatedWork W3135767091 @default.
- W2041468663 hasRelatedWork W3200026446 @default.
- W2041468663 hasRelatedWork W4223432098 @default.
- W2041468663 hasRelatedWork W873261229 @default.
- W2041468663 hasVolume "12" @default.
- W2041468663 isParatext "false" @default.
- W2041468663 isRetracted "false" @default.
- W2041468663 magId "2041468663" @default.
- W2041468663 workType "article" @default.